hydroxyproline has been researched along with thromboxane a2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hinz, JM; Molteni, A; Ts'ao, CH; Ward, WF | 1 |
Cui, WY; Long, CL; Wang, H; Zhang, YF; Zhong, ML; Zhou, HM | 1 |
2 other study(ies) available for hydroxyproline and thromboxane a2
Article | Year |
---|---|
Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
Topics: Animals; Cardiomegaly; Chlorobenzoates; Epoprostenol; Hydroxyproline; Lung Diseases; Male; Monocrotaline; Organ Size; Pancreatic Elastase; Peptidyl-Dipeptidase A; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thromboxane A2; Tissue Plasminogen Activator | 1989 |
Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.
Topics: Administration, Oral; Allyl Compounds; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Epoprostenol; Heart Failure; Heart Ventricles; Hydroxyproline; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Nitric Oxide; Propylamines; Rats; Rats, Wistar; Thromboxane A2; Ventricular Remodeling | 2014 |